Literature DB >> 17909168

Relationship of SERT polymorphisms to depressive and anxiety symptoms in irritable bowel syndrome.

Monica E Jarrett1, Ruth Kohen, Kevin C Cain, Robert L Burr, Ann Poppe, Grace P Navaja, Margaret M Heitkemper.   

Abstract

This study investigates the association of psychological symptoms with the distribution of two serotonin transporter gene (SERT) polymorphisms, located in the promoter region (5-HTTLPR) and in intron 2 (STin2 VNTR), in patients with irritable bowel syndrome (IBS). Participants, 21 men and 117 women, were assessed for mental health history and current psychological distress. A blood sample was used for genotyping. Participants who were homozygous for the short allele of 5-HTTLPR or carried a STin2.9 VNTR allele were significantly more likely to have a history of depression. Participants did not differ by genotype in their history of anxiety or suicidal ideation nor in their current levels of depression, anxiety, or general psychological distress. The results support a biopsychosocial model of IBS in which SERT genotype modifies the risk for depressive episodes. Long term, practitioners may individualize treatment of patients with IBS using genotype as one of the factors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17909168     DOI: 10.1177/1099800407307822

Source DB:  PubMed          Journal:  Biol Res Nurs        ISSN: 1099-8004            Impact factor:   2.522


  31 in total

Review 1.  The heritability of postpartum depression.

Authors:  Elizabeth J Corwin; Ruth Kohen; Monica Jarrett; Brian Stafford
Journal:  Biol Res Nurs       Date:  2010-05-07       Impact factor: 2.522

Review 2.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.

Authors:  Michael Camilleri; David A Katzka
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

3.  Associations of tryptophan hydroxylase gene polymorphisms with irritable bowel syndrome.

Authors:  S Jun; R Kohen; K C Cain; M E Jarrett; M M Heitkemper
Journal:  Neurogastroenterol Motil       Date:  2010-11-12       Impact factor: 3.598

4.  Rare Variants of the Serotonin Transporter Are Associated With Psychiatric Comorbidity in Irritable Bowel Syndrome.

Authors:  Ruth Kohen; Julia H Tracy; Eric Haugen; Kevin C Cain; Monica E Jarrett; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2016-02-24       Impact factor: 2.522

5.  Psychological dysfunction is associated with symptom severity but not disease etiology or degree of gastric retention in patients with gastroparesis.

Authors:  William L Hasler; Henry P Parkman; Laura A Wilson; Pankaj J Pasricha; Kenneth L Koch; Thomas L Abell; William J Snape; Gianrico Farrugia; Linda Lee; James Tonascia; Aynur Unalp-Arida; Frank Hamilton
Journal:  Am J Gastroenterol       Date:  2010-06-29       Impact factor: 10.864

Review 6.  Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets.

Authors:  Gary M Mawe; Jill M Hoffman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-06-25       Impact factor: 46.802

7.  Association of serotonin transporter gene polymorphisms with poststroke depression.

Authors:  Ruth Kohen; Kevin C Cain; Pamela H Mitchell; Kyra Becker; Ann Buzaitis; Steven P Millard; Grace P Navaja; Linda Teri; David Tirschwell; Richard Veith
Journal:  Arch Gen Psychiatry       Date:  2008-11

Review 8.  Molecular basis of the irritable bowel syndrome.

Authors:  Anna Vaiopoulou; Georgios Karamanolis; Theodora Psaltopoulou; George Karatzias; Maria Gazouli
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

9.  Clinical implications of genetic variation in the serotonin transporter promoter region: a review.

Authors:  Nicole S Luddington; Anitha Mandadapu; Margaret Husk; Rif S El-Mallakh
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

Review 10.  Genetics of human gastrointestinal sensation.

Authors:  M Camilleri
Journal:  Neurogastroenterol Motil       Date:  2013-04-17       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.